T-cell receptor

Oct 31, 2017

TCR2 Therapeutics to Present New Data from its TRuC(TM) T Cell Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 11, 2017

TCR2 Therapeutics Appoints Leading Cell Therapy Expert as Chief Medical Officer

Sep 15, 2017

TCR2 Therapeutics Named One of the 15 Innovative Immuno-Oncology Biotechs to Watch in 2018 by Immuno-Oncology Frontiers

Aug 31, 2017

Tactiva Therapeutics to Present Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer at BioCentury's 24th Annual Newsmakers Conference

Aug 29, 2017

TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Aug 08, 2017

TCR2 Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference

Jun 13, 2017

TCR(2) Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC(TM) Engineered T Cell Therapies at the World Preclinical Congress

Jun 07, 2017

TCR2 Therapeutics to Debut Positive Solid Tumor Data on its Novel TRuC(TM) Engineered T Cell Platform at the World Preclinical Congress